Drugs Made in America Ac-RTSDMAARPreferred / convertible
13F holders, Q1 2025 (March 31)19holders
$0.18avg. 13F price*
At the end of Q1 2025, 19 institutions reported holding Drugs Made in America Ac-RTS (DMAAR) in their 13F filings. The largest holders were Crossingbridge Advisors, LLC ($807K), Polar Asset Management Partners Inc. ($247K) and Hudson Bay Capital Management LP ($234K).
- Company
- Drugs Made in America Ac-RTS
- CUSIP
- G2847J112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 19 | $2.5M |
| Exits | 0 | $0 |
Ownership 19 holders
| Crossingbridge Advisors, LLC | — | New | 850,000 | $807K |
| Polar Asset Management Partners Inc. | — | New | 1,900,000 | $247K |
| Hudson Bay Capital Management LP | — | New | 1,800,000 | $234K |
| Harraden Circle Investments, LLC | — | New | 1,500,000 | $195K |
| Glazer Capital, LLC | — | New | 1,300,000 | $169K |
| Aristeia Capital, L.L.C. | — | New | 900,000 | $117K |
| Highbridge Capital Management LLC | — | New | 850,000 | $111K |
| Mangrove Partners Im, LLC | — | New | 850,000 | $111K |
| Wolverine Asset Management LLC | — | New | 603,038 | $78K |
| Atw Spac Management LLC | — | New | 570,000 | $74K |
| Clear Street LLC | — | New | 550,176 | $72K |
| Cantor Fitzgerald, L. P. | — | New | 500,000 | $65K |
| AQR Arbitrage LLC | — | New | 500,000 | $65K |
| LMR Partners LLP | — | New | 500,000 | $65K |
| Whitebox Advisors LLC | — | New | 400,000 | $52K |
| Schonfeld Strategic Advisors LLC | — | New | 200,000 | $26K |
| Mizuho Securities USA LLC | — | New | 209,897 | $21K |
| Quarry LP | — | New | 150,000 | $20K |
| Warberg Asset Management LLC | — | New | 18,443 | $2K |
"% of holder's portfolio" is DMAAR's weight in each manager's 13F, not the share of Drugs Made in America Ac-RTS the manager owns.